Gut Barrier Function and Microbiota Modulation

The gut barrier comprises a multilayered defence system that regulates passage of nutrients, water and immune signals while preventing microbial translocation. Key components include a mucus layer, a single layer of specialised epithelial cells joined by tight and adherens junctions, secreted antimicrobial peptides and resident immune cells. The gut microbiota—an intricate community of bacteria, archaea, viruses and fungi—interacts dynamically with this barrier. Beneficial microbes produce metabolites such as short-chain fatty acids (SCFAs) that nourish epithelial cells, reinforce junctional complexes and modulate mucosal immunity. Disruption of this equilibrium by antibiotics, infection or dietary imbalances can lead to increased permeability (‘leaky gut’), inflammation and heightened risk of metabolic, autoimmune and infectious diseases. Targeted modulation of the microbiota through diet, prebiotics, probiotics or synbiotics has emerged as a promising strategy to enhance barrier integrity, restore homeostasis and support global health, with potential applications ranging from inflammatory bowel disease management to infection prevention.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Gut Barrier Function and Microbiota Modulation publication trend

The graph below shows the total number of articles in gut barrier function and microbiota modulation across all publications each year (not limited to Nature Index journals).

Technical terms

Gut barrier: A complex defence interface comprising mucus, epithelial cells and immune components that controls permeability and prevents pathogen entry.

Tight junction proteins: Transmembrane and scaffold proteins (e.g. occludin, claudins, ZO-1) that seal intercellular spaces between epithelial cells to regulate paracellular transport.

Microbiota modulation: Intentional alteration of the gut microbial community through diet, prebiotics, probiotics or drugs to achieve a health benefit.

Short-chain fatty acids (SCFAs): Metabolites (acetate, propionate, butyrate) produced by microbial fermentation of dietary fibres that support epithelial energy metabolism and immune regulation.

Galactooligosaccharides (GOS): Non-digestible prebiotic oligosaccharides that selectively stimulate growth of beneficial gut bacteria and confer barrier-protective effects.

NF-κB pathway: A central intracellular signalling cascade that regulates inflammatory gene expression in response to microbial and cytokine stimuli.

References

1. Galactooligosaccharide Mediates NF-κB Pathway to Improve Intestinal Barrier Function and Intestinal Microbiota. Molecules (2023).
2. Galacto-oligosaccharides improve barrier function and relieve colonic inflammation via modulating mucosa-associated microbiota composition in lipopolysaccharides-challenged piglets. Journal of Animal Science and Biotechnology (2021).
3. Protection of Galacto-Oligosaccharide against E. coli O157 Colonization through Enhancing Gut Barrier Function and Modulating Gut Microbiota. Foods (2020).